Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
M.D. Anderson Cancer Center
China Medical University, China
Mayo Clinic
Jonsson Comprehensive Cancer Center
Mayo Clinic
RenJi Hospital
Mayo Clinic
Tampere University Hospital
University of Erlangen-Nürnberg Medical School
Jonsson Comprehensive Cancer Center
NuCana plc
University of Virginia
Affiliated Hospital of Jiangnan University
Affiliated Hospital of Jiangnan University
UNICANCER
SOLTI Breast Cancer Research Group
Sarcoma Oncology Research Center, LLC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
European Institute of Oncology
Universitair Ziekenhuis Brussel
University of Florida
Northwestern University
Institut Bergonié
Herlev Hospital
Ludwig Institute for Cancer Research